Catalyst Biosciences, Inc. (CBIO) Financials

NASDAQ Currency in USD Disclaimer

$0.51

north_east NA Past Year
Day's range
$0.48
Day's range
$0.58

CBIO Income statement / Annual

Last year (2022), Catalyst Biosciences, Inc.'s total revenue was $794,000.00, a decrease of 89.18% from the previous year. In 2022, Catalyst Biosciences, Inc.'s net income was -$8.24 M. See Catalyst Biosciences, Inc.�s key income statements, including revenue, expenses, profit, and income.

Period FY-2022 FY-2021 FY-2020 FY-2019 FY-2018 FY-2017 FY-2016 FY-2015 FY-2014 FY-2013
Period Ended 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015 12/31/2014 12/31/2013
Operating Revenue $794,000.00 $7.34 M $20.95 M $0.00 $6,000.00 $1.02 M $399,000.00 $1.75 M $275,000.00 $3.63 M
Cost of Revenue $798,000.00 $7.38 M $9.16 M $43.86 M $21.47 M $12.85 M $10.56 M $5.96 M $5.27 M $6.56 M
Gross Profit -$4,000.00 -$42,000.00 $11.79 M -$43.86 M -$21.47 M -$11.83 M -$10.16 M -$4.21 M -$4.99 M -$2.93 M
Gross Profit Ratio -0.01 -0.01 0.56 0 -3578 -11.62 -25.45 -2.4 -18.15 -0.81
Research and Development Expenses $13.04 M $68.89 M $52.98 M $43.86 M $21.47 M $12.85 M $11.56 M $5.96 M $19.50 M $38.84 M
General & Administrative Expenses $17.37 M $18.96 M $16.18 M $13.42 M $12.35 M $9.99 M $9.26 M $9.59 M $10.17 M $12.01 M
Selling & Marketing Expenses $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Selling, General & Administrative Expenses $17.37 M $18.96 M $16.18 M $13.42 M $12.35 M $9.99 M $9.26 M $9.59 M $10.17 M $12.01 M
Other Expenses $0.00 -$78,000.00 $568,000.00 -$46,000.00 $1.65 M $261,000.00 $86,000.00 $0.00 $318,000.00 $518,000.00
Operating Expenses $30.40 M $87.85 M $69.16 M $57.28 M $33.83 M $22.84 M $20.82 M $15.55 M $29.67 M $50.85 M
Cost And Expenses $31.20 M $95.23 M $78.32 M $57.28 M $33.83 M $22.84 M $20.82 M $15.55 M $29.67 M $50.85 M
Interest Income $537,000.00 $39,000.00 $1.13 M $2.10 M $3.77 M $261,000.00 $3.47 M $518,000.00 $585,000.00 $784,000.00
Interest Expense $717,000.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $1.48 M $23,000.00 $53,000.00
Depreciation & Amortization -$43.54 M $290,000.00 $138,000.00 $146,000.00 $149,000.00 $173,000.00 $389,000.00 $470,000.00 $351,000.00 $547,000.00
EBITDA -$52.15 M -$87.60 M -$57.37 M -$57.28 M -$33.82 M -$21.82 M -$16.95 M -$12.81 M -$28.46 M -$47.22 M
EBITDA Ratio -65.68 -11.94 -2.74 0 -5637 -21.44 -42.47 -7.32 -103.49 -13.01
Operating Income Ratio -10.85 -11.98 -2.74 0 -5637 -21.44 -51.17 -7.89 -108.05 -13.01
Total Other Income/Expenses Net $717,000.00 -$39,000.00 $1.13 M $2.10 M $3.77 M $261,000.00 $3.47 M -$960,000.00 $575,000.00 $518,000.00
Income Before Tax -$7.89 M -$87.93 M -$56.24 M -$55.18 M -$30.06 M -$21.56 M -$16.95 M -$14.76 M -$29.14 M -$46.70 M
Income Before Tax Ratio -9.94 -11.98 -2.68 0 -5009.17 -21.18 -42.47 -8.44 -105.96 -12.87
Income Tax Expense $348,000.00 -$39,000.00 -$699,000.00 -$2.29 M $3.77 M -$173,000.00 $3.08 M $518,000.00 $3.48 M $7,000.00
Net Income -$8.24 M -$87.89 M -$55.54 M -$52.89 M -$30.06 M -$21.56 M -$16.95 M -$14.76 M -$32.62 M -$46.71 M
Net Income Ratio -10.38 -11.98 -2.65 0 -5009.17 -21.18 -42.47 -8.44 -118.63 -12.87
EPS -0.26 -2.87 -2.9 -4.41 -2.68 -6.3 -21.76 -49.99 -101.4 -145.78
EPS Diluted -0.26 -2.87 -2.9 -4.41 -2.68 -6.3 -21.76 -49.99 -101.4 -145.78
Weighted Average Shares Out $31.55 M $30.64 M $19.18 M $12.00 M $11.21 M $3.42 M $778,780.00 $295,272.00 $321,719.00 $320,385.00
Weighted Average Shares Out Diluted $31.55 M $30.64 M $19.18 M $12.00 M $11.21 M $3.42 M $778,780.00 $295,272.00 $321,719.00 $320,385.00
Link